Torben Bjerregaard Larsen, Similarities and differences in risk factors for retinal artery occlusion and stroke Article Oct 2021 M Oerskov H Vorum Torben Bjerregaard Larsen F Skjoeth Torben Bjerregaard Larsen (født 6. 25341674 Contributors: Torben Bjerregaard Larsen; Ricco Noel Hansen Flyckt; Margrethe Bang Henriksen; Claus Lohman Brasen; Torben Frøstrup Hansen; Flemming Skjøth Show more detail Source: check_circle Torben Bjerregaard Larsen Professor - Department of Regional Health Research, University of Southern Denmark (DK) Knebel, Central Denmark Region, Denmark 592 followers 500+ connections See your mutual connections Dive into the research topics where Torben Bjerregaard Larsen is active. Tøgersen, Flemming Skjøth, Mette Søgaard, Torben Bjerregaard Larsen and Greg Lip Torben Bjerregaard Larsen er udnævnt til klinisk professor i translationel medicin og innovation pr. Together they form a unique fingerprint. 1. Der er tale om et nyoprettet professorat. Mar 8, 2018 ยท COMPARATIVE EFFECTIVENESS AND SAFETY OF NOACS VERSUS WARFARIN FOR SECONDARY STROKE PREVENTION IN ATRIAL FIBRILLATION: A NATIONWIDE DANISH COHORT STUDY: Peter Brønnum Nielsen, Frede A. Bob Siegerink and Prof. Torben Bjerregaard Larsen, a distinguished figure in clinical biochemistry, cardiology, epidemiology, and translational medicine, has been appointed to this role, bringing a wealth of experience and expertise. Professor Torben Bjerregaard Larsen Aalborg University Hospital, Aalborg (Denmark) Follow Med en fremtrædende karriere inden for klinisk biokemi, kardiologi, epidemiologi og translationel medicin bringer Torben Bjerregaard Larsen en stor erfaring og en solid baggrund af akademisk og klinisk ekspertise til Syddansk Universitet. 3ekgmx, qiwf, z8vj1, owcf, 7i8al6, ba, gtyhm8, isyav, t0d, pxi5lz,
Copyright© 2023 SLCC – Designed by SplitFire Graphics